124 related articles for article (PubMed ID: 37996324)
1. Comment on "Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma".
Singh S; Sarode G; Sengupta N; Anand R; Sarode S
J Formos Med Assoc; 2024 Mar; 123(3):415. PubMed ID: 37996324
[No Abstract] [Full Text] [Related]
2. Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
Sekar D
Oral Oncol; 2022 Mar; 126():105763. PubMed ID: 35144207
[No Abstract] [Full Text] [Related]
3. Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma.
Shie WY; Cheng SJ; Chen KC; Tang CC; Peng HH; Ko HH; Hou HH; Elizabeth Chou HY
J Formos Med Assoc; 2024 Mar; 123(3):390-399. PubMed ID: 37704482
[TBL] [Abstract][Full Text] [Related]
4. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
5. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
6. Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
Yang X; Zhou T; Ji T; Jia H; Liu W
Oral Oncol; 2022 Jul; 130():105901. PubMed ID: 35533509
[No Abstract] [Full Text] [Related]
7. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
8. Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Sekar D
Oral Oncol; 2023 Feb; 137():106306. PubMed ID: 36623474
[No Abstract] [Full Text] [Related]
9. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
10. Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Zhang S; Han X; Wang M; Shen X
Oral Oncol; 2023 Feb; 137():106298. PubMed ID: 36584496
[No Abstract] [Full Text] [Related]
11. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
12. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
Ye X; Zhang J; Lu R; Zhou G
Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
[TBL] [Abstract][Full Text] [Related]
13. RET protein is overexpressed in oral squamous cell carcinoma.
Koole K; Peeters T; van Hengel OR; Brinkhuis A; van Es RJ; Willems SM
Histopathology; 2016 Dec; 69(6):1085-1087. PubMed ID: 27344057
[No Abstract] [Full Text] [Related]
14. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
Babkair H; Yamazaki M; Uddin MS; Maruyama S; Abé T; Essa A; Sumita Y; Ahsan MS; Swelam W; Cheng J; Saku T
Hum Pathol; 2016 Nov; 57():51-60. PubMed ID: 27436828
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells.
Al-Eryani K; Cheng J; Abé T; Maruyama S; Yamazaki M; Babkair H; Essa A; Saku T
Hum Pathol; 2015 Jul; 46(7):991-9. PubMed ID: 25912757
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.
Nakashima T; Yasumatsu R; Masuda M; Clayman GL; Komune S
J Laryngol Otol; 2012 Nov; 126(11):1134-7. PubMed ID: 22963824
[TBL] [Abstract][Full Text] [Related]
17. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients.
Velmurugan BK; Yeh KT; Lee CH; Lin SH; Chin MC; Chiang SL; Wang ZH; Hua CH; Tsai MH; Chang JG; Ko YC
Oncotarget; 2016 Mar; 7(10):10879-90. PubMed ID: 26918356
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
19. S4S8-RPA phosphorylation as an indicator of cancer progression in oral squamous cell carcinomas.
Rector J; Kapil S; Treude KJ; Kumm P; Glanzer JG; Byrne BM; Liu S; Smith LM; DiMaio DJ; Giannini P; Smith RB; Oakley GG
Oncotarget; 2017 Feb; 8(6):9243-9250. PubMed ID: 27999209
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-2 expression in oral squamous cell carcinoma.
Campagna R; Pozzi V; Salvucci A; Togni L; Mascitti M; Sartini D; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Hum Cell; 2023 May; 36(3):1211-1213. PubMed ID: 36774414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
